about
Imaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patientsProbing the Heterogeneity of Protein Kinase Activation in Cells by Super-resolution Microscopy3D super-resolution imaging with blinking quantum dots.Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patientsDetecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor[18F]tetrafluoroborate-PET/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor modelA multi-functional imaging approach to high-content protein interaction screeningKinase-mediated quasi-dimers of EGFRRhoA and RhoC have distinct roles in migration and invasion by acting through different targets.The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.Two-photon 3D FIONA of individual quantum dots in an aqueous environmentNMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation.Fluorescence lifetime endoscopy using TCSPC for the measurement of FRET in live cells.MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibitionOxidized phospholipids: from molecular properties to disease.Hydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy.Mediation of apoptosis by oxidized phospholipids.How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology.The challenges of integrating molecular imaging into the optimization of cancer therapy.RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers.18F-Fluorosulfate for PET Imaging of the Sodium-Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo.Fluorescence axial nanotomography with plasmonics.A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments.Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.A cellular screening assay using analysis of metal-modified fluorescence lifetimeVisualisation of signalling in immune cells.The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells.Simultaneous FRAP, FLIM and FAIM for measurements of protein mobility and interaction in living cells.The alphaPROX assay: fluorescence screening of the inhibitory effects of hydrophilic antioxidants on protein oxidation.Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models.Opportunities and Challenges for Metal Chemistry in Molecular ImagingIn Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal AlendronateCousins at work: How combining medical with optical imaging enhances in vivo cell trackingRegional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune MicroenvironmentThe Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer ImmunotherapiesIntegrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast CancerThe clinical potential of gene editing as a tool to engineer cell-based therapeuticsReporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible68Ga-Sienna+ for PET-MRI Guided Sentinel Lymph Node Biopsy: Synthesis and Preclinical Evaluation in a Metastatic Breast Cancer Model
P50
Q26858812-B414894F-A38F-4555-AF6F-BC3C6E213F0BQ30364872-00F08CFE-DD02-40CB-8528-BDE1D5C28E74Q30560943-A957FB07-4742-4B0C-B01F-7ABA5B59EDE8Q30829681-6D8F46F5-1CB0-4975-B2FA-C8928461C55EQ33503737-626BE1BB-38B4-4D5C-AFDB-AF5F353D3E61Q33647681-A3E25D66-E3E1-491E-9369-3B0778349625Q33680923-C9129FF1-1EB3-4894-BD1D-264C312680EDQ34233520-AC6DB413-61CE-4FB4-A3B0-4617BE1C1825Q34352792-B87FE1D8-23EB-47DB-9B92-64AC057B5F65Q35196063-176C3A4B-8E0F-4CDF-AAC1-1C41F3FE4173Q35228445-8FF39B0F-1F8D-4629-B758-FFAC7D5FDB90Q35333114-C9BD2ECC-5E83-41D8-8059-4295037569A5Q36043738-DEEBF6A7-1639-4BA2-951F-48674ECEB189Q36129895-17FDAF03-B01D-4541-97D1-E0A0ADF2D73AQ36265149-6363E94D-4812-4191-A8B9-8DB643C766ABQ36849829-7336B715-513E-499A-BF83-89301B500CF4Q37088862-FD45B392-173E-407A-B0DE-6C4C1120CC1DQ37254322-F9A7179A-1464-4F8D-A649-E2F2FE4C9585Q37843988-3AA134AF-FE38-45C9-8E07-4941E3E89B46Q37871875-93476ADE-6F6F-4F54-B909-DEE604F19B33Q38721561-E3D304A4-6856-4134-B4F8-082B8E1F1B92Q38751151-F1D88DEE-4325-4990-845E-B5C398D4B327Q38906466-3507A1AB-4C95-49A5-9AA3-20BA655B817CQ39017717-9A8947D4-39E3-418A-AB71-9457D465CF84Q39062014-F7A14818-52B0-4C1E-B30C-277DCF59007FQ39698272-78562156-D4F9-4E27-AC6A-573FC71E3CABQ39716855-6E64D8B0-C174-4060-9CD6-0210989052D8Q40244459-0979B2BB-CCA8-4278-A84B-A9ECF856DBCBQ40389375-FE43773E-EC06-4175-84FF-1834C7A675E8Q46914068-5C60C68F-804A-4ECA-AD58-4556CF49E21EQ51731081-FB6B7DDB-DA69-48CD-8175-9A066135D812Q58147397-814B9854-CDF0-46DE-9E15-51E30FB04E6FQ59102162-A3450C38-B6D8-4DF5-B2E4-212A8821B286Q59162015-CAF02AAD-2023-4A13-931B-3426D7C8DC49Q61797822-C3F13907-5D88-4A4C-8AC4-2DFF53584008Q64030468-C47AE70F-58C9-4202-9B5E-3300BE7CE281Q64269743-F84D4605-2D3D-4720-8574-AD52E777D528Q89604473-9F639F64-B940-44F4-85B7-FF95655226EBQ91211284-63996D2A-D6B5-4D2B-B629-C3FB62816AC3Q91533932-A53D4E83-1679-429A-BD59-99B7006D8653
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gilbert Fruhwirth
@ast
Gilbert Fruhwirth
@en
Gilbert Fruhwirth
@es
Gilbert Fruhwirth
@nl
type
label
Gilbert Fruhwirth
@ast
Gilbert Fruhwirth
@en
Gilbert Fruhwirth
@es
Gilbert Fruhwirth
@nl
prefLabel
Gilbert Fruhwirth
@ast
Gilbert Fruhwirth
@en
Gilbert Fruhwirth
@es
Gilbert Fruhwirth
@nl
P106
P1153
6507547753
P21
P31
P496
0000-0002-1438-2674